The global C-reactive protein testing market revenue was around US$ 2,765.07 million in 2021 and is estimated to reach US$ 3,588.9 million by 2030, growing at a compound annual growth rate (CAGR) of 2 ...

A new study in Calgary hospitals highlights the need to optimise latent tuberculosis testing prior to patient hospitalisation ...

The most prominent of the newer risk factors has been C-reactive protein (CRP), based on numerous ... provide a stable estimate of hs-CRP. If the level is >10 mg/L, a source of overt inflammation ...

For over 30 years, Life Line Screening has provided preventive health screenings for stroke and cardiovascular disease risk in community-based buildings. Its screenings are noninvasive, painless ...

So if we can understand the ways in which chronic stress leads to low-level inflammation, we may be able to avoid at least some of that inflammation before it leads to or worsens disease.

Phase 2 results were positive for ILYX-002, a topical immunomodulator for moderate to severe dry eye disease associated with systemic autoimmune or inflammatory conditions, according to a press ...